Results 171 to 180 of about 5,935 (185)

Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy

Catheterization and Cardiovascular Interventions, 2001

exaly  

Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: A meta-analysis of 8 randomized trials

Atherosclerosis, 2012
Giuseppe De Luca, Mónica Verdoia
exaly  

A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention

Circulation: Cardiovascular Interventions, 2009
Pascal Meier, Hitinder Gurm
exaly  

Management of coronary artery aneurysms using abciximab in children with Kawasaki disease

International Journal of Cardiology, 2016
George P Chrousos, Athanasios Michos
exaly  

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

Lancet, The, 2002
Markus Schwaiger, Stephan G Nekolla, Melchior Seyfarth   +2 more
exaly  

Different effects of abciximab and cytochalasin D on clot strength in thrombelastography

Journal of Thrombosis and Haemostasis, 2004
exaly  

Intracerebral Hemorrhages Associated With Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab

Stroke, 2002
Michael Alexander, JOSÉ Suarez, Adnan Qureshi   +2 more
exaly  

Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial

International Journal of Cardiology, 2009
Josep Rodes-Cabau, Eric Larose
exaly  

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

Journal of Thrombosis and Haemostasis, 2004
exaly  

T cell mediated allergy to abciximab

Allergy: European Journal of Allergy and Clinical Immunology, 2002
exaly